TENAX THERAPEUTICS, INC. — Director's Dealing 2012

Feb 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXYGEN BIOTHERAPEUTICS, INC. (oxbt)
CIK: 0000034956
Period of Report: 2011-06-24

Reporting Person: BLANCK RONALD R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-06-24	Common stock	A	7490	$2.52	Acquired	7490	Direct
2011-11-01	Common stock	A	9538	$2.11	Acquired	17028	Direct